Pre-check is rule-based, not medical advice. Consult a healthcare professional for personalised guidance.
Interaction analysis is based on peer-reviewed pharmacology. PMID links go to PubMed. Not medical advice.
1000mg
Aniracetam was part of a symptomatic treatment that showed efficacy in improving cognitive dysfunction.
The pharmacokinetics of aniracetam showed a Tmax of 0.4 hours & a Cmax of approximately 8.7 ng/mL.
No significant changes in neuropsychological symptoms were observed with aniracetam treatment.
300mg
GI discomfort (nausea, cramping) — one of the most common side effects; always take with food
Cognitive slowing in first weeks; benefits accumulate and emerge after 8–12 weeks of consistent use
Possible mild reduction in thyroid hormones (T4) — caution with thyroid conditions
Reliable improvement in delayed recall & processing speed; effect grows with duration.
Discussion
Similar community stacks
Avoid reinventing the wheel: fork a community stack that matches your category tags, then edit it.
Cognitive & Mood Support
Pramiracetam & phenylalanine are combined to support cognitive function & mood. Pramiracetam enhances memory & cognitive performance, while phenylalanine supports mood & cognitive function by acting as a precursor to neurotransmitters.
Cognitive & Mood Enhancement
Phenylpiracetam & CDP-choline are combined to enhance cognitive function & mood. Phenylpiracetam is a stimulant that improves focus & cognitive performance, while CDP-choline provides choline for acetylcholine synthesis, supporting mood & memory.
Focus Stack (No Stimulants)
Supports focus & mental clarity without stimulants.